BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20738039)

  • 1. Postmenopausal hormone replacement therapy and meningioma.
    Prescrire Int; 2010 Jun; 19(107):120. PubMed ID: 20738039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland.
    Korhonen K; Auvinen A; Lyytinen H; Ylikorkala O; Pukkala E
    Am J Epidemiol; 2012 Feb; 175(4):309-14. PubMed ID: 22287638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous hormone use and meningioma risk: what do we tell our patients?
    Claus EB; Black PM; Bondy ML; Calvocoressi L; Schildkraut JM; Wiemels JL; Wrensch M
    Cancer; 2007 Aug; 110(3):471-6. PubMed ID: 17580362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland.
    Korhonen K; Raitanen J; Isola J; Haapasalo H; Salminen T; Auvinen A
    Cancer Causes Control; 2010 Dec; 21(12):2149-56. PubMed ID: 20730482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study.
    Custer B; Longstreth WT; Phillips LE; Koepsell TD; Van Belle G
    BMC Cancer; 2006 Jun; 6():152. PubMed ID: 16759391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and risk of meningioma in women: a meta-analysis.
    Fan ZX; Shen J; Wu YY; Yu H; Zhu Y; Zhan RY
    Cancer Causes Control; 2013 Aug; 24(8):1517-25. PubMed ID: 23702884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a symptomatic intracranial meningioma in a male-to-female transsexual after initiation of hormone therapy.
    Deipolyi AR; Han SJ; Parsa AT
    J Clin Neurosci; 2010 Oct; 17(10):1324-6. PubMed ID: 20594855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an association between meningioma and hormone replacement therapy?
    Blitshteyn S; Crook JE; Jaeckle KA
    J Clin Oncol; 2008 Jan; 26(2):279-82. PubMed ID: 18182668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone therapy and brain tumors.
    Pines A
    Climacteric; 2011 Apr; 14(2):215-6. PubMed ID: 21067422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of brain tumors associated with exposure to exogenous female sex hormones.
    Wigertz A; Lönn S; Mathiesen T; Ahlbom A; Hall P; Feychting M;
    Am J Epidemiol; 2006 Oct; 164(7):629-36. PubMed ID: 16835295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
    Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
    Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multiple basaloma and meningioma following long-term arsenic therapy].
    Weiss J; Jänner M
    Hautarzt; 1980 Dec; 31(12):654-56. PubMed ID: 7204019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of a meningioma in a transsexual patient after estrogen-progestin therapy.
    Gazzeri R; Galarza M; Gazzeri G
    N Engl J Med; 2007 Dec; 357(23):2411-2. PubMed ID: 18057351
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users.
    Thorp JM; Gavin NI; Ohsfeldt RL
    Am J Obstet Gynecol; 2001 Aug; 185(2):318-26. PubMed ID: 11518885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socio-demographic characteristics of postmenopausal estrogen users.
    Strinić T; Buković D; Karelović D; Despot A; Buković N; Giudici E; Silovski H
    Coll Antropol; 2002 Jun; 26(1):245-9. PubMed ID: 12137306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone therapy and central nervous system tumors: Danish nested case-control study.
    Pourhadi N; Meaidi A; Friis S; Torp-Pedersen C; Mørch LS
    PLoS Med; 2023 Dec; 20(12):e1004321. PubMed ID: 38113227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hot flashes resistant to hormone replacement in menopausal women: panic disorder?].
    van der Feltz-Cornelis CM
    Ned Tijdschr Geneeskd; 1999 Feb; 143(6):281-4. PubMed ID: 10221080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.